Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma

Neil D. Gross; David M. Miller; Nikhil I. Khushalani; Vasu Divi; Emily S. Ruiz; Evan J. Lipson; Friedegund Meier; Yungpo B. Su; Paul L. Swiecicki; Jennifer Atlas

doi:10.1056/nejmoa2209813

Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma

Identifier:nobleid.org/w1/20260526/263199F2

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/263199F2.svg?ark=w1%2F20260526%2F263199F2)](https://nobleid.org/work/w1/20260526/263199F2)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma

Identifier:nobleid.org/w1/20260526/263199F2

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/263199F2.svg?ark=w1%2F20260526%2F263199F2)](https://nobleid.org/work/w1/20260526/263199F2)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work